References
- Ohm J. Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzung von Luft in den Glaskörper. Graefes Arch. Clin. Exp. Ophthalmol.79, 442–450 (1911).
- Feigenbaum A, Kornbluth W. Intravitreal injection of penicillin in a case of incipient abscess of the vitreous following extracapsular cataract extraction; perfect cure. Ophthalmologica 110, 300–305 (1945).
- Sorsby A, Ungar J. Intravitreal injection of penicillin; study on the levels of concentration reached and therapeutic efficacy. Br. J. Ophthalmol. 32, 857–864 (1948).
- Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br. J. Ophthalmol. 96(6), 862–866 (2012).
- Moshfeghi AA. Endophthalmitis following intravitreal antivascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin. Ophthalmol. 26(3), 139–148 (2011).
- McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of antivascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina (PA, USA) 31(4), 654–661 (2011).
- Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Corey RP, Miller D. Endophthalmitis caused by Streptococcus pneumoniae. Am. J. Ophthalmol. 138(2), 231–236 (2004).
- Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116(1), 57–65.e5 (2009).
- Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90(11), 1344–1349 (2006).
- Scott IU, Flynn HW Jr. Reducing the risk of endophthalmitis following intravitreal injections. Retina (PA, USA) 27(1), 10–12 (2007).
- Pilli S, Kotsolis A, Spaide RF et al. Endophthalmitis associated with intravitreal antivascular endothelial growth factor therapy injections in an office setting. Am. J. Ophthalmol. 145(5), 879–882 (2008).
- Mason JO 3rd, White MF, Feist RM et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina (PA, USA) 28(4), 564–567 (2008).
- Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am. J. Ophthalmol. 151(2), 329–332 (2011).
- Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 116(8), 1498–1501 (2009).
- Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina (PA, USA) 31(10), 2032–2036 (2011).
- Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC et al. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119(8), 1609–1614 (2012).
- Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 119(7), 1420–1424 (2012).
- Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117(12), 2372–2378 (2010).
- Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch. Ophthalmol. 129(9), 1180–1188 (2011).
- Dave SB, Toma HS, Kim SJ. Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology 118(10), 2035–2040 (2011).